DK1147112T3 - Diazabicykliske derivater som nicotiniske acetylcholinreceptorligander - Google Patents

Diazabicykliske derivater som nicotiniske acetylcholinreceptorligander

Info

Publication number: DK1147112T3
Authority: DK; Denmark
Prior art keywords: acetylcholine receptor; receptor ligands; nicotinic acetylcholine; diazabicyclic; derivatives
Prior art date: 1999-01-29

Application number

DK00906998T

Other languages

English (en)

Inventor

William H Bunnelle

Daniela Barlocco Cristina

Jerome F Daanen

Michael J Dart

Michael D Meyer

Keith B Ryther

Michael R Schrimpf

Kevin B Sippy

Richard B Toupence

Original Assignee

Abbott Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-01-29

Filing date

2000-01-25

Publication date

2004-02-23

2000-01-25 Application filed by Abbott Lab filed Critical Abbott Lab

2004-02-23 Application granted granted Critical

2004-02-23 Publication of DK1147112T3 publication Critical patent/DK1147112T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing alicyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing alicyclic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/08—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing alicyclic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Addiction (AREA)
Endocrinology (AREA)
Urology & Nephrology (AREA)
Reproductive Health (AREA)
Vascular Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Rheumatology (AREA)
Cardiology (AREA)
Anesthesiology (AREA)
Gynecology & Obstetrics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK00906998T 1999-01-29 2000-01-25 Diazabicykliske derivater som nicotiniske acetylcholinreceptorligander DK1147112T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US23983899A	1999-01-29	1999-01-29
PCT/US2000/001620 WO2000044755A1 (en)	1999-01-29	2000-01-25	Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands

Publications (1)

Publication Number	Publication Date
DK1147112T3 true DK1147112T3 (da)	2004-02-23

Family

ID=22903947

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK00906998T DK1147112T3 (da)	1999-01-29	2000-01-25	Diazabicykliske derivater som nicotiniske acetylcholinreceptorligander

Country Status (26)

Country	Link
EP (2)	EP1147112B1 (da)
JP (1)	JP4676062B2 (da)
KR (1)	KR20010101725A (da)
CN (2)	CN1636996A (da)
AR (1)	AR034538A1 (da)
AT (2)	ATE394401T1 (da)
AU (1)	AU773795B2 (da)
BG (1)	BG105836A (da)
BR (1)	BR0007664A (da)
CA (1)	CA2361525C (da)
CO (1)	CO5150231A1 (da)
CZ (1)	CZ20012716A3 (da)
DE (2)	DE60038823D1 (da)
DK (1)	DK1147112T3 (da)
ES (2)	ES2209825T3 (da)
HK (1)	HK1043116B (da)
HU (1)	HUP0200332A3 (da)
IL (1)	IL144340A0 (da)
NO (1)	NO20013731L (da)
NZ (1)	NZ512884A (da)
PT (1)	PT1147112E (da)
SK (1)	SK10692001A3 (da)
TR (1)	TR200102162T2 (da)
TW (1)	TW200300021A (da)
WO (1)	WO2000044755A1 (da)
ZA (1)	ZA200105835B (da)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6605610B1 (en) *	1997-12-31	2003-08-12	Pfizer Inc	Aryl fused azapolycyclic compounds
ATE386024T1 (de) *	1997-12-31	2008-03-15	Pfizer Prod Inc	Arylkondensierte azapolycyclische derivate
WO2001044243A2 (en) *	1999-12-14	2001-06-21	Neurosearch A/S	Novel heteroaryl-diazabicycloalkanes
MY145722A (en) *	2000-04-27	2012-03-30	Abbott Lab	Diazabicyclic central nervous system active agents
US6809105B2 (en)	2000-04-27	2004-10-26	Abbott Laboratories	Diazabicyclic central nervous system active agents
US6852721B2 (en)	2000-05-25	2005-02-08	Targacept, Inc.	Pharmaceutical compositions and methods for use
US6440970B1 (en)	2000-05-25	2002-08-27	Targacept, Inc.	Pharmaceutical compositions and methods for use
CA2410945A1 (en) *	2000-07-04	2002-01-10	Neurosearch A/S	Aryl and heteroaryl diazabicycloalkanes, their preparation and use
US6624167B1 (en)	2000-08-04	2003-09-23	Targacept, Inc.	Pharmaceutical compositions and methods for use
DE60202667T2 (de) *	2001-03-02	2005-06-16	Neurosearch A/S	Neue 2,5-diazabicyclo [2.2.1] heptanderivate
DE60203007T2 (de) *	2001-06-01	2005-07-07	Neurosearch A/S	Heteroaryl-diazabicycloalkanderivaten als cns-modulatoren
AR036041A1 (es) *	2001-06-12	2004-08-04	Upjohn Co	Compuestos aromaticos heterociclicos sustituidos con quinuclidina y composiciones farmaceuticas que los contienen
US7390813B1 (en)	2001-12-21	2008-06-24	Xenon Pharmaceuticals Inc.	Pyridylpiperazines and aminonicotinamides and their use as therapeutic agents
WO2003062235A1 (en) *	2002-01-17	2003-07-31	Eli Lilly And Company	Modulators of acetylcholine receptors
MXPA04010966A (es)	2002-05-07	2005-01-25	Neurosearch As	Derivados novedosos de biarilo diazabiciclico.
US7135484B2 (en)	2002-08-14	2006-11-14	Abbott Laboratories	Azabicyclic compounds are central nervous system active agents
US20040242641A1 (en) *	2003-05-27	2004-12-02	Buckley Michael J.	(1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane is an effective analgesic agent
US7763618B2 (en) *	2003-07-29	2010-07-27	Xenon Pharmaceuticals Inc.	Pyridyl derivatives and their use as therapeutic agents
TW201038270A (en)	2003-07-30	2010-11-01	Xenon Pharmaceuticals Inc	Pyridazine derivatives and their use in the inhibition of stearoyl-CoA desaturase
US20050065178A1 (en) *	2003-09-19	2005-03-24	Anwer Basha	Substituted diazabicycloakane derivatives
US7399765B2 (en)	2003-09-19	2008-07-15	Abbott Laboratories	Substituted diazabicycloalkane derivatives
NZ546990A (en)	2003-11-20	2010-03-26	Janssen Pharmaceutica Nv	7-Phenylalkyl substituted 2-quinolinones and 2 quinoxalinones as poly(adp-ribose) polymerase inhibitors
SG150533A1 (en)	2003-11-20	2009-03-30	Janssen Pharmaceutica Nv	6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2- quinoxalinones as poly(adp-ribose) polymerase inhibitors
JP4824578B2 (ja) *	2003-12-22	2011-11-30	メモリー・ファーマシューティカルズ・コーポレイション	インドール類、１，２−ベンズイソオキサゾール類、および１，２−ベンゾイソチアゾール類、ならびにそれらの製造と使用
WO2005074940A1 (en)	2004-02-04	2005-08-18	Neurosearch A/S	Diazabicyclic aryl derivatives as cholinergic receptor modulators
US20050171079A1 (en) *	2004-02-04	2005-08-04	Schrimpf Michael R.	Amino-substituted tricyclic derivatives and methods of use
US7365193B2 (en)	2004-02-04	2008-04-29	Abbott Laboratories	Amino-substituted tricyclic derivatives and methods of use
WO2006001894A1 (en) *	2004-04-22	2006-01-05	Memory Pharmaceutical Corporation	Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof
ITMI20040954A1 (it) *	2004-05-12	2004-08-12	Univ Degli Studi Milano	Derivati del 3,6-diazabiciclo 3.1.i.eptano ad attivita' analgesica
WO2006003148A1 (en)	2004-06-30	2006-01-12	Janssen Pharmaceutica N.V.	Quinazolinedione derivatives as parp inhibitors
CN1976906B (zh)	2004-06-30	2010-09-01	詹森药业有限公司	用作parp抑制剂的取代2-烷基喹唑啉酮衍生物
AU2005259189B2 (en)	2004-06-30	2011-04-21	Janssen Pharmaceutica N.V.	Phthalazine derivatives as PARP inhibitors
AU2005284908B2 (en)	2004-09-13	2011-12-08	Morningside Venture Investments Limited	Biosynchronous transdermal drug delivery
US8071603B2 (en)	2004-09-20	2011-12-06	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
CA2580857A1 (en)	2004-09-20	2006-09-28	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
MX2007003318A (es)	2004-09-20	2007-05-18	Xenon Pharmaceuticals Inc	Derivados heterociclicos y su uso como agentes terapeuticos.
CN101084212A (zh)	2004-09-20	2007-12-05	泽农医药公司	杂环衍生物及其作为硬脂酰CoA去饱和酶介导剂的用途
CA2580855A1 (en)	2004-09-20	2006-03-30	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
TW200626138A (en)	2004-09-20	2006-08-01	Xenon Pharmaceuticals Inc	Heterocyclic derivatives and their use as therapeutic agents
MX2007003319A (es)	2004-09-20	2007-06-05	Xenon Pharmaceuticals Inc	Derivados heterociclicos y su uso como agentes terapeuticos.
WO2006087305A1 (en)	2005-02-16	2006-08-24	Neurosearch A/S	Novel diazabicyclic aryl derivatives and their medical use
DE602006019561D1 (de)	2005-02-16	2011-02-24	Neurosearch As	Diazabicyclische arylderivate und ihre verwendung als chinolinergische liganden an nikotin-acetylcholin-rezeptoren
EP2029138A1 (en)	2005-06-03	2009-03-04	Xenon Pharmaceuticals Inc.	Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
CN101305004B (zh)	2005-12-06	2011-11-16	神经研究公司	新颖的二氮杂双环芳基衍生物和它们的医药用途
WO2007090888A1 (en)	2006-02-10	2007-08-16	Neurosearch A/S	3-heteroaryl- 3,9-diazabicyclo[3.3.1]nonane derivatives as nicotinic acetylcholine receptor agonists
CN101448828B (zh) *	2006-02-10	2011-12-07	神经研究公司	作为烟碱性乙酰胆碱受体激动剂的3-杂芳基-3,9-二氮杂双环[3.3.1]壬烷衍生物
EP1984366B1 (en)	2006-02-10	2010-12-15	NeuroSearch A/S	3, 9-diazabicyclo ý3.3. 1¨nonane derivatives and their use as monoamine?neurotransmitter re-uptake inhibitors
CN101379063A (zh)	2006-02-10	2009-03-04	神经研究公司	3,9-二氮杂双环[3.3.1]壬烷衍生物及其作为单胺神经递质再摄取抑制剂的用途
WO2007093600A1 (en) *	2006-02-14	2007-08-23	Neurosearch A/S	Novel diazabicycloalkane derivatives and their medical use
US7855208B2 (en)	2006-02-14	2010-12-21	Neurosearch A/S	3, 9-diazabicyclo(3.3.1)non-3-yl-aryl methanone derivatives as nicotinic acetylcholine receptor agonists
HRP20110917T1 (hr)	2006-05-19	2012-03-31	Abbott Laboratories	Derivati azabicikličkih alkana supstituirani fuzioniranim bicikloheterociklima aktivni u središnjem živčanom sustavu
US7910578B2 (en)	2006-05-23	2011-03-22	Neurosearch A/S	8,10-diaza-bicyclo[4.3.1]decane derivatives and their medical use
JP2009543785A (ja) *	2006-07-14	2009-12-10	メルクエンドカムパニーインコーポレーテッド	架橋ジアゼパンオレキシン受容体アンタゴニスト
US8076350B2 (en)	2006-12-22	2011-12-13	Abbott Laboratories	Spirocyclic azaadamantane derivatives and methods of use
JP5545955B2 (ja)	2007-03-08	2014-07-09	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	Ｐａｒｐおよびｔａｎｋ阻害剤としてのキノリノン誘導体
ES2521494T3 (es)	2007-04-02	2014-11-12	Parkinson's Institute	Métodos y composiciones para la reducción de los efectos secundarios de tratamientos terapéuticos
JP2010527924A (ja) *	2007-05-18	2010-08-19	メルク・シャープ・エンド・ドーム・コーポレイション	オキソ架橋ジアゼパンオレキシン受容体アンタゴニスト
US8404713B2 (en)	2007-10-26	2013-03-26	Janssen Pharmaceutica Nv	Quinolinone derivatives as PARP inhibitors
WO2009081246A2 (en) *	2007-12-19	2009-07-02	Pfizer Inc.	Bicyclic diamines as nicotinic receptor agonists
AU2009228945B2 (en)	2008-03-27	2013-05-02	Janssen Pharmaceutica Nv	Quinazolinone derivatives as tubulin polymerization inhibitors
JP5492183B2 (ja)	2008-03-27	2014-05-14	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	Ｐａｒｐおよびチューブリン重合阻害剤としてのテトラヒドロフェナントリジノンおよびテトラヒドロシクロペンタキノリノン
US8148408B2 (en) *	2008-05-09	2012-04-03	Abbott Laboratories	Selective substituted pyridine ligands for neuronal nicotinic receptors
TW201004963A (en) *	2008-07-03	2010-02-01	Targacept Inc	Derivatives of oxabispidine as neuronal nicotinic acetylcholine receptor ligands
MX2011003306A (es) *	2008-10-14	2011-09-01	Psychogenics Inc	Ligandos nicotinicos de receptor de acetilcolina y los usos de los mismos.
KR101925971B1 (ko) *	2011-01-28	2018-12-06	에스케이바이오팜 주식회사	피리돈 유도체 및 이를 포함하는 약학적 조성물
WO2013016160A1 (en) *	2011-07-26	2013-01-31	Merck Sharp & Dohme Corp.	NOVEL IMIDAZO[1,2-A]PYRAZINE DERIVATIVES AS mTOR INHIBITORS
WO2013050938A1 (en) *	2011-10-04	2013-04-11	Actelion Pharmaceuticals Ltd	3,7-diazabicyclo[3.3.1]nonane and 9-oxa-3,7-diazabicyclo[3.3.1]nonane derivatives
US20150031675A1 (en) *	2012-02-02	2015-01-29	Targacept, Inc.	Diazabicyclo[3.3.1]nonanes, methods of synthesis, and uses thereof
CN102952134B (zh) *	2012-12-05	2015-01-07	苏州药明康德检测检验有限责任公司	含二氟甲基的金雀花碱衍生物及制备方法和抗癌作用研究
US10231970B2 (en)	2014-09-30	2019-03-19	NV Heterocycles	Methods of producing heteropolycycles via bis-epoxidation
WO2016123406A1 (en)	2015-01-28	2016-08-04	Chrono Therapeutics Inc.	Drug delivery methods and systems
CA3049529A1 (en)	2017-01-06	2018-07-12	Chrono Therapeutics Inc.	Transdermal drug delivery devices and methods
US20180311238A1 (en) *	2017-04-28	2018-11-01	Saniona A/S	Selective Agonist Of a6 Containing nAChRs
CA3101966A1 (en)	2018-05-29	2019-12-05	Morningside Venture Investments Limited	Drug delivery methods and systems
US12397141B2 (en)	2018-11-16	2025-08-26	Morningside Venture Investments Limited	Thermally regulated transdermal drug delivery system
AR117169A1 (es)	2018-11-28	2021-07-14	Bayer Ag	(tio)amidas de piridazina como compuestos fungicidas
TWI840477B (en)	2018-12-20	2024-05-01	德商拜耳廠股份有限公司	Heterocyclyl pyridazine as fungicidal compounds
JP7760531B2 (ja)	2020-05-27	2025-10-27	バイエル、アクチエンゲゼルシャフト	活性化合物の組合せ物
KR20230038704A (ko)	2020-06-18	2023-03-21	바이엘 악티엔게젤샤프트	활성 화합물 조합물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5478939A (en) *	1994-07-20	1995-12-26	American Cyanamid Company	(R,R) and (S,S) 2,5-diazabicyclo [2,2,1]heptane derivatives
EE04057B1 (et) *	1997-05-30	2003-06-16	Neurosearch A/S	8-asabitsüklo[3,2,1]okt-2-eeni ja -oktaani derivaadid, nende valmistamismeetod, kasutamine ja farmatseutiline kompositsioon
AU736798B2 (en) *	1997-05-30	2001-08-02	Neurosearch A/S	9-Azabicyclo(3.3.1)non-2-ene and nonane derivatives as cholinergic ligands at nicotinic ACh receptors
FR2786769B1 (fr) *	1998-12-04	2002-10-25	Synthelabo	Derives de 2,5-diazabicyclo[2.2.1]heptane, leur preparation et leur application en therapeutique

2000
- 2000-01-25 PT PT00906998T patent/PT1147112E/pt unknown
- 2000-01-25 EP EP00906998A patent/EP1147112B1/en not_active Expired - Lifetime
- 2000-01-25 HK HK02102948.7A patent/HK1043116B/en not_active IP Right Cessation
- 2000-01-25 AU AU28569/00A patent/AU773795B2/en not_active Ceased
- 2000-01-25 HU HU0200332A patent/HUP0200332A3/hu unknown
- 2000-01-25 EP EP03017562A patent/EP1359152B1/en not_active Expired - Lifetime
- 2000-01-25 JP JP2000596011A patent/JP4676062B2/ja not_active Expired - Fee Related
- 2000-01-25 SK SK1069-2001A patent/SK10692001A3/sk unknown
- 2000-01-25 IL IL14434000A patent/IL144340A0/xx unknown
- 2000-01-25 DE DE60038823T patent/DE60038823D1/de not_active Expired - Lifetime
- 2000-01-25 ES ES00906998T patent/ES2209825T3/es not_active Expired - Lifetime
- 2000-01-25 WO PCT/US2000/001620 patent/WO2000044755A1/en not_active Ceased
- 2000-01-25 CZ CZ20012716A patent/CZ20012716A3/cs unknown
- 2000-01-25 CN CNA2004100974823A patent/CN1636996A/zh active Pending
- 2000-01-25 CN CN00805544A patent/CN1345320A/zh active Pending
- 2000-01-25 KR KR1020017009420A patent/KR20010101725A/ko not_active Ceased
- 2000-01-25 CA CA002361525A patent/CA2361525C/en not_active Expired - Fee Related
- 2000-01-25 NZ NZ512884A patent/NZ512884A/xx unknown
- 2000-01-25 AT AT03017562T patent/ATE394401T1/de not_active IP Right Cessation
- 2000-01-25 TR TR2001/02162T patent/TR200102162T2/xx unknown
- 2000-01-25 BR BR0007664-3A patent/BR0007664A/pt not_active IP Right Cessation
- 2000-01-25 AT AT00906998T patent/ATE253067T1/de active
- 2000-01-25 ES ES03017562T patent/ES2305373T3/es not_active Expired - Lifetime
- 2000-01-25 DE DE60006213T patent/DE60006213T2/de not_active Expired - Lifetime
- 2000-01-25 DK DK00906998T patent/DK1147112T3/da active
- 2000-01-26 CO CO00004294A patent/CO5150231A1/es unknown
- 2000-01-28 AR ARP000100393A patent/AR034538A1/es not_active Application Discontinuation
- 2000-03-01 TW TW091133012A patent/TW200300021A/zh unknown
2001
- 2001-07-16 ZA ZA200105835A patent/ZA200105835B/en unknown
- 2001-07-30 NO NO20013731A patent/NO20013731L/no not_active Application Discontinuation
- 2001-08-22 BG BG105836A patent/BG105836A/xx unknown

Also Published As

Publication number	Publication date
SK10692001A3 (sk)	2002-01-07
BG105836A (en)	2002-03-29
AU773795B2 (en)	2004-06-03
ES2305373T3 (es)	2008-11-01
CO5150231A1 (es)	2002-04-29
JP4676062B2 (ja)	2011-04-27
HK1043116A1 (en)	2002-09-06
CA2361525C (en)	2009-12-08
KR20010101725A (ko)	2001-11-14
ZA200105835B (en)	2002-10-16
IL144340A0 (en)	2002-05-23
CN1636996A (zh)	2005-07-13
PT1147112E (pt)	2004-03-31
EP1147112B1 (en)	2003-10-29
CA2361525A1 (en)	2000-08-03
ATE394401T1 (de)	2008-05-15
WO2000044755A1 (en)	2000-08-03
HK1043116B (en)	2004-10-15
EP1359152A3 (en)	2003-12-17
NO20013731D0 (no)	2001-07-30
HUP0200332A3 (en)	2002-09-30
DE60006213T2 (de)	2004-07-29
HUP0200332A2 (en)	2002-06-29
JP2002535409A (ja)	2002-10-22
CN1345320A (zh)	2002-04-17
AU2856900A (en)	2000-08-18
NO20013731L (no)	2001-09-18
ATE253067T1 (de)	2003-11-15
BR0007664A (pt)	2002-05-07
TW200300021A (en)	2003-05-01
EP1147112A1 (en)	2001-10-24
CZ20012716A3 (cs)	2001-11-14
EP1359152A2 (en)	2003-11-05
AR034538A1 (es)	2004-03-03
DE60038823D1 (de)	2008-06-19
DE60006213D1 (de)	2003-12-04
EP1359152B1 (en)	2008-05-07
NZ512884A (en)	2004-03-26
ES2209825T3 (es)	2004-07-01
TR200102162T2 (tr)	2001-12-21

Publication	Publication Date	Title
DK1147112T3 (da)	2004-02-23	Diazabicykliske derivater som nicotiniske acetylcholinreceptorligander
NO20013671D0 (no)	2001-07-26	Substituerte bicycliske derivater nyttige som anticancer midler
DK1381363T3 (da)	2005-04-18	Imidazo[1,2-a]pyridinderivater som mGluR5-antagonister
DK1173440T3 (da)	2004-12-20	Tetracycliske azepinoindolforbindelser som 5-HT receptorligander
NO20013909L (no)	2001-10-08	Heteroaryl-substituerte kinolin-2-on derivater nyttige som anticancer midler
PT1218378E (pt)	2003-09-30	Derivados de terc-butil-(7-metil-imidazo-¬1,2-a\|-piridin-3-il)-amina
CY2011002I1 (el)	2012-01-25	N-πυρραζολικοι αγωνιστες του α2α υποδοχεα
ATE293618T1 (de)	2005-05-15	4, 5, 6, 7-tetrahydroindazolderivate als antitumormittel
DK1200431T3 (da)	2003-07-21	Quinuclidinderivater og deres anvendelse som muskarine M3-receptorligander
NO20043174L (no)	2004-07-26	Pyrido[2,1-a]isokinolinderivater som DPP-IV inhibitorer
DE60039550D1 (de)	2008-09-04	Tonabhängige Fehlerdiffusion
ATE305470T1 (de)	2005-10-15	Naphthyridinverbindungen
NO20015172D0 (no)	2001-10-23	1-Metyl-erytromycin-derivater
DK1442036T3 (da)	2006-05-15	Heteroarylderivater som fortræffelige ligander for nociceptinreceptor ORL-1
NO20020457D0 (no)	2002-01-29	Benzenaminderivater som antikoagulanter
DK1347974T3 (da)	2005-03-14	Aminotriazolopyridinderivater som adenosinreceptorligander
DE60003072D1 (de)	2003-07-03	Thiazolidindion-derivate als antidiabetika
ATE315025T1 (de)	2006-02-15	Ethansulfonyl-piperidin-derivate
DK1149096T3 (da)	2003-04-07	Tricykliske pyridin-N-oxider som vasopressinagonister
IL148667A0 (en)	2002-09-12	Nicotinic acetylcholine receptor
NO20000183D0 (no)	2000-01-14	5-substituerte-3-oksadiazolyl-1,6-naftyridin-2(1H)-on- derivater
IT1314085B1 (it)	2002-12-04	Gruppo di foratura particolarmente studiato per macchine per lafresatura e la foratura di pannelli.
NO20031412L (no)	2003-04-22	Substituerte 3,4-dihydro-pyrido[1,2-A]pyrimidiner
SI1147112T1 (en)	2004-04-30	Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands
DK1178045T3 (da)	2003-06-23	Azaindol-ethylaminderivater som nikotinacetylcholinreceptor-bindingsmidler